Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
34.85
+0.06 (0.17%)
Sep 2, 2026, 11:29 AM EDT - Market open

Sanara MedTech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
109.81103.1286.6764.9945.8424.14
Revenue Growth
12.96%18.97%33.36%41.77%89.87%54.90%
Gross Profit
102.1695.678.5357.1439.4821.83
Operating Income
10.269.151.75-7.67-12.05-7.38
Net Income
-32.01-37.56-9.66-4.3-7.94-7.92
Earnings Per Share
-3.69-4.36-1.14-0.52-1.00-1.08
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
15.4216.5815.885.158.9618.65
Total Debt
48.5348.1932.2911.790.820.43
Net Cash (Debt)
-33.11-31.61-16.41-6.648.1418.23
Net Cash Growth
-----55.34%-
Net Cash Per Share
-3.81-3.67-1.93-0.801.032.48

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
5.696.79-0.02-3.25-5.55-4.81
Capital Expenditures
-1.19-4.63-0.21-0.27-0.15-0.17
Free Cash Flow
4.52.16-0.23-3.51-5.7-4.99
Free Cash Flow Growth
5368.05%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
93.03%92.71%90.61%87.92%86.13%90.43%
Operating Margin
9.34%8.87%2.02%-11.79%-26.27%-30.55%
Pretax Margin
-0.26%-0.38%-2.24%-6.83%-30.40%-33.11%
Profit Margin
-29.15%-36.43%-11.15%-6.62%-17.32%-32.81%
FCF Margin
4.10%2.10%-0.27%-5.40%-12.44%-20.65%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
104.6320.1369.71178.70--
P/FCF Ratio
71.0796.55----
PS Ratio
2.922.023.355.408.249.34